Interim 4'-[methyl-
PET
Squamous cell carcinoma
[11C]4DST
[18F]FDG
Journal
EJNMMI research
ISSN: 2191-219X
Titre abrégé: EJNMMI Res
Pays: Germany
ID NLM: 101560946
Informations de publication
Date de publication:
10 Feb 2021
10 Feb 2021
Historique:
received:
06
11
2020
accepted:
05
01
2021
entrez:
10
2
2021
pubmed:
11
2
2021
medline:
11
2
2021
Statut:
epublish
Résumé
We investigated the potential of interim 4'-[methyl- A total of 32 patients with HNSCC who underwent both [ All patients showed increased uptake in primary tumor on baseline [ These preliminary results suggest that interim [
Identifiants
pubmed: 33566186
doi: 10.1186/s13550-021-00749-y
pii: 10.1186/s13550-021-00749-y
pmc: PMC7876213
doi:
Types de publication
Journal Article
Langues
eng
Pagination
13Références
Ann Otol Rhinol Laryngol. 2004 Aug;113(8):628-35
pubmed: 15330142
J Nucl Med. 2009 Jul;50(7):1028-35
pubmed: 19525472
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2147-2154
pubmed: 27251644
EJNMMI Res. 2019 Jan 16;9(1):4
pubmed: 30649637
Head Neck. 2001 Nov;23(11):942-6
pubmed: 11754497
Nucl Med Commun. 2015 Mar;36(3):219-25
pubmed: 25369751
Semin Nucl Med. 2009 May;39(3):210-32
pubmed: 19341841
Ann Nucl Med. 2017 Jan;31(1):63-70
pubmed: 27679399
Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1203-11
pubmed: 21350962
J Nucl Med. 2014 Jun;55(6):884-90
pubmed: 24752671
EJNMMI Phys. 2014 Dec;1(1):12
pubmed: 26501454
J Nucl Med. 2012 Oct;53(10):1521-7
pubmed: 22872738
Br J Radiol. 2015 Apr;88(1048):20140655
pubmed: 25634069
Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2122-2138
pubmed: 29948105
Anticancer Res. 1996 Jul-Aug;16(4C):2397-402
pubmed: 8816841
Clin Otolaryngol. 2008 Jun;33(3):210-22
pubmed: 18559026
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):938-42
pubmed: 20932677
J Nucl Med. 1992 Nov;33(11):1972-80
pubmed: 1432158
J Nucl Med. 2011 Aug;52(8):1322-8
pubmed: 21764794
Ann Nucl Med. 2013 May;27(4):363-70
pubmed: 23378102